IRWD: Ironwood Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 603.31
Enterprise Value ($M) 1,113.91
Book Value ($M) -311.33
Book Value / Share -1.95
Price / Book -1.94
NCAV ($M) -522.25
NCAV / Share -3.26
Price / NCAV -1.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.01
Return on Assets (ROA) -0.01
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.62
Current Ratio 3.62

Balance Sheet (mrq) ($M)
Current Assets 178.60
Assets 389.52
Liabilities 700.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G Armistice Capital, Llc 5.13
11-12 13G/A Vanguard Group Inc 13.79 0.00
11-08 13G/A BlackRock, Inc. 14.30 0.00
10-16 13G/A State Street Corp 6.20 -13.98
02-09 13G/A Lsv Asset Management 4.35 -14.29

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 163,172 785,722 20.77
2025-01-13 520,395 1,898,270 27.41
2025-01-10 266,077 1,369,633 19.43

(click for more detail)

Similar Companies
IOBT – IO Biotech, Inc. IONS – Ionis Pharmaceuticals, Inc.
IPSC – Century Therapeutics, Inc. ITCI – Intra-Cellular Therapies, Inc.
JAZZ – Jazz Pharmaceuticals plc


Financial data and stock pages provided by
Fintel.io